info.3se@keehealthcare.com

Pyeloplasty for UPJ Obstruction

“Pyeloplasty is the surgical reconstruction of the renal pelvis (a part of the kidney) to drain and decompress the kidney. In nearly all cases, the goal of the surgery is to relieve a uretero-pelvic junction (UPJ) obstruction. Pyeloplasty is done to clear a blockage where the renal pelvis connects with the ureter, the tube that carries urine from the kidneys to the bladder. This narrowing causes dilation of the kidney, a condition called hydronephrosis. Hydronephrosis can usually be verified with an ultrasound and kidney scan. The original ureter is surgically approached below the level of the obstruction and the abnormal section is removed. Then the ureter is repositioned and reattached to the healthy renal pelvic tissue above. The surgery can be done from a few different angles. In general, the incision will be on your child’s side. Your surgeon will discuss the location of the incision that is most appropriate for your child. All the surgical stitches, called sutures, will dissolve. Occasionally, one skin suture is removed 10 days or so after the operation if a tube is inserted. Surgeons use different approaches. In some cases, no tubes are left in place. In other cases, a tube called a “”stent”” may be left for seven to 10 days to drain the ureter, or a kidney catheter tube called a nephrostomy may remain for 10 to 12 days. A small drain made of special soft rubber, called a Penrose drain, may be left under the incision. The tube or drains are removed in the office. Removal causes minimal, brief discomfort, although it may feel strange. Occasionally, a small amount of reddish-brown drainage comes out of the tubes or drains. The skin around the tubes may redden and have pus-like secretions. This is a natural reaction to the drain and nothing to be alarmed about. Before you take your child home, we will help you get comfortable assessing and caring for the tube. While in the hospital, your child will have a catheter in his or her bladder to assure that the bladder and kidney aren’t stressed. Your child may experience bladder spasms or intermittent cramping. A medication called Ditropan will provide relief. The catheter will be removed before your child goes home. The surgery takes about two to three hours.”

How it works?

1.

Request for medicine

Patient who has serious problem request for medicine

 

2.

Drug Verify

Internal processing of drug verifications at GM Global

 

3.

Prescription

Recognizing best source for the specific prescription

 

4.

GDP Instruction

Import medicine under the GDP instruction

 

5.

QA check

Supply drugs to concerned healthcare provider after QA check

 

5.

QA check

Supply drugs to concerned healthcare provider after QA check

 

FAQ

A NPP provides access to post-approval drugs that are approved and commercially available in one or more country, other than the patient’s home country.

 

No. Companies are not required to provide their products through a formal NPP.

 

  • Dealing with unsolicited patient request for drug in an ethical and regulatory controlled manner
  • Providing exposure to, and experience with, company products to physicians in additional countries and build a larger KOL network and future advocates
  • Providing new products to patients who would move to commercial drug when it becomes available in these countries
  • Generating additional revenues in countries that allow you to charge for drugs supplied on a named patient basis

Companies can provide drug to patients in any country in which they have not yet received marketing approval. This includes countries in which a company plans to seek marketing approval, as well as those countries in which a company does not plan to seek marketing approval.

 
 

INFORMATION FOR PATIENTS

As a named patient medicines you may find yourself in the frightening position that you have a serious condition or illness and the treatment you need is not available in your home country. It is possible that the medicines are available outside your country and if your physician decides that these drugs would be suitable for the treatment of your illness, they then face the challenge of obtaining them for you. We help physicians across the world access medicines which are not approved or licensed in their country, but may be required to meet the special needs of an individual patient. The service we provide not only locates and supplies the required medicines but ensures that the physician has all the quality assurance and supporting clinical information they will need to safely prescribe it to you. If you are confronted with a situation where a drug is not available to you, talk to your physician or healthcare professional about Named Patient Program and ask them to contact us. We will then work directly with your physician to help them in patient access program and understand what options are available.

 

 

Drugs We Provide Under NPS

Drug Directory

Orphan Drugs

1.

Request for medicine

Patient who has serious problem request for medicine

 

2.

Drug Verify

Internal processing of drug verifications at GM Global

 

3.

Prescription

Recognizing best source for the specific prescription

 

4.

GDP Instruction

Import medicine under the GDP instruction

 

5.

QA check

Supply drugs to concerned healthcare provider after QA check

 

5.

QA check

Supply drugs to concerned healthcare provider after QA check

 

FAQ

A NPP provides access to post-approval drugs that are approved and commercially available in one or more country, other than the patient’s home country.

 

No. Companies are not required to provide their products through a formal NPP.

 

  • Dealing with unsolicited patient request for drug in an ethical and regulatory controlled manner
  • Providing exposure to, and experience with, company products to physicians in additional countries and build a larger KOL network and future advocates
  • Providing new products to patients who would move to commercial drug when it becomes available in these countries
  • Generating additional revenues in countries that allow you to charge for drugs supplied on a named patient basis

Companies can provide drug to patients in any country in which they have not yet received marketing approval. This includes countries in which a company plans to seek marketing approval, as well as those countries in which a company does not plan to seek marketing approval.

 
 

INFORMATION FOR PATIENTS

As a named patient medicines you may find yourself in the frightening position that you have a serious condition or illness and the treatment you need is not available in your home country. It is possible that the medicines are available outside your country and if your physician decides that these drugs would be suitable for the treatment of your illness, they then face the challenge of obtaining them for you. We help physicians across the world access medicines which are not approved or licensed in their country, but may be required to meet the special needs of an individual patient. The service we provide not only locates and supplies the required medicines but ensures that the physician has all the quality assurance and supporting clinical information they will need to safely prescribe it to you. If you are confronted with a situation where a drug is not available to you, talk to your physician or healthcare professional about Named Patient Program and ask them to contact us. We will then work directly with your physician to help them in patient access program and understand what options are available.